Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Analysis of the role of ZEB1 in the pathogenesis of posterior polymorphous corneal dystrophy.

Yellore VS, Rayner SA, Nguyen CK, Gangalum RK, Jing Z, Bhat SP, Aldave AJ.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):273-8. doi: 10.1167/iovs.11-8038.

2.

Investigating the Molecular Basis of PPCD3: Characterization of ZEB1 Regulation of COL4A3 Expression.

Chung DW, Frausto RF, Chiu S, Lin BR, Aldave AJ.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4136-43. doi: 10.1167/iovs.16-19533.

3.

Zeb1 mutant mice as a model of posterior corneal dystrophy.

Liu Y, Peng X, Tan J, Darling DS, Kaplan HJ, Dean DC.

Invest Ophthalmol Vis Sci. 2008 May;49(5):1843-9. doi: 10.1167/iovs.07-0789.

4.

Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells.

Krafchak CM, Pawar H, Moroi SE, Sugar A, Lichter PR, Mackey DA, Mian S, Nairus T, Elner V, Schteingart MT, Downs CA, Kijek TG, Johnson JM, Trager EH, Rozsa FW, Mandal MN, Epstein MP, Vollrath D, Ayyagari R, Boehnke M, Richards JE.

Am J Hum Genet. 2005 Nov;77(5):694-708. Epub 2005 Sep 14.

5.

Mutational spectrum of the ZEB1 gene in corneal dystrophies supports a genotype-phenotype correlation.

Lechner J, Dash DP, Muszynska D, Hosseini M, Segev F, George S, Frazer DG, Moore JE, Kaye SB, Young T, Simpson DA, Churchill AJ, Héon E, Willoughby CE.

Invest Ophthalmol Vis Sci. 2013 May 3;54(5):3215-23. doi: 10.1167/iovs.13-11781.

PMID:
23599324
6.

Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy.

Chung DD, Frausto RF, Lin BR, Hanser EM, Cohen Z, Aldave AJ.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3202-3214. doi: 10.1167/iovs.17-21423.

7.

Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening.

Aldave AJ, Ann LB, Frausto RF, Nguyen CK, Yu F, Raber IM.

JAMA Ophthalmol. 2013 Dec;131(12):1583-90. doi: 10.1001/jamaophthalmol.2013.5036.

8.

Further genetic and clinical insights of posterior polymorphous corneal dystrophy 3.

Liskova P, Palos M, Hardcastle AJ, Vincent AL.

JAMA Ophthalmol. 2013 Oct;131(10):1296-303. doi: 10.1001/jamaophthalmol.2013.405.

PMID:
23807282
9.

Functional impact of ZEB1 mutations associated with posterior polymorphous and Fuchs' endothelial corneal dystrophies.

Chung DW, Frausto RF, Ann LB, Jang MS, Aldave AJ.

Invest Ophthalmol Vis Sci. 2014 Sep 4;55(10):6159-66. doi: 10.1167/iovs.14-15247.

11.

Identification of six novel mutations in ZEB1 and description of the associated phenotypes in patients with posterior polymorphous corneal dystrophy 3.

Evans CJ, Liskova P, Dudakova L, Hrabcikova P, Horinek A, Jirsova K, Filipec M, Hardcastle AJ, Davidson AE, Tuft SJ.

Ann Hum Genet. 2015 Jan;79(1):1-9. doi: 10.1111/ahg.12090. Epub 2014 Dec 1.

12.

Elucidating the molecular basis of PPCD: Effects of decreased ZEB1 expression on corneal endothelial cell function.

Zakharevich M, Kattan JM, Chen JL, Lin BR, Cervantes AE, Chung DD, Frausto RF, Aldave AJ.

Mol Vis. 2017 Oct 14;23:740-752. eCollection 2017.

13.

Clinical phenotype of posterior polymorphous corneal dystrophy in a family with a novel ZEB1 mutation.

Nguyen DQ, Hosseini M, Billingsley G, Héon E, Churchill AJ.

Acta Ophthalmol. 2010 Sep;88(6):695-9. doi: 10.1111/j.1755-3768.2009.01511.x.

14.

Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population.

Vincent AL, Niederer RL, Richards A, Karolyi B, Patel DV, McGhee CN.

Mol Vis. 2009 Dec 3;15:2544-53.

15.

Confirmation of the OVOL2 Promoter Mutation c.-307T>C in Posterior Polymorphous Corneal Dystrophy 1.

Chung DD, Frausto RF, Cervantes AE, Gee KM, Zakharevich M, Hanser EM, Stone EM, Heon E, Aldave AJ.

PLoS One. 2017 Jan 3;12(1):e0169215. doi: 10.1371/journal.pone.0169215. eCollection 2017.

16.

Effect of CTCF-binding motif on regulation of PAX6 transcription.

Wu D, Li T, Lu Z, Dai W, Xu M, Lu L.

Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2422-9. Erratum in: Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3721.

PMID:
16723452
17.

Variable ocular phenotypes of posterior polymorphous corneal dystrophy caused by mutations in the ZEB1 gene.

Liskova P, Filipec M, Merjava S, Jirsova K, Tuft SJ.

Ophthalmic Genet. 2010 Dec;31(4):230-4. doi: 10.3109/13816810.2010.518577.

PMID:
21067486
18.

Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum.

Jang MS, Roldan AN, Frausto RF, Aldave AJ.

Vision Res. 2014 Jul;100:88-92. doi: 10.1016/j.visres.2014.04.007. Epub 2014 Apr 26.

19.

Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.

Li S, Gallup M, Chen YT, McNamara NA.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2466-75. doi: 10.1167/iovs.09-4677. Epub 2009 Dec 30.

20.

Transcriptome analysis of the human corneal endothelium.

Frausto RF, Wang C, Aldave AJ.

Invest Ophthalmol Vis Sci. 2014 Nov 6;55(12):7821-30. doi: 10.1167/iovs.14-15021.

Supplemental Content

Support Center